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Summary: An enzyme-linked immunosorbent assay to detect antinuclear antibodies in the sera of patients
with autoimmune diseases is described. Goat liver nuclei were immobilized on polystyrene plates and
antinuclear antibodies were used to standardize the assay. The effects of variables, such as the nuclei
concentration, conditions of nuclei storage, and the length of the incubation period were investigated on the
assay. Prototype sera with known antibody specificity were used to evaluate the assay. The method described
is highly sensitive, autoantibodies being detectable at serum dilutions of 1 : 1000 or higher. According to the
intra- and inter-assay coefficient of variation, the results were highly reproducible.
Introduction
Enzyme immunoassays have been successfully em-
ployed for the quantitation of human autoantibodies
of defined specificities using purified antigen adsorbed
on a solid matrix (reviewed in I.e. (1)). Some varia-
tions of the procedure include the use of nylon beads
as the solid support (2—4) instead of a conventional
polystyrene surface, and the use of a fluorogenic sub-
strate (5) for the evaluation of enzyme activity.
In the present work, an enzyme-linked immunosor-
bent assay (ELISA) was evaluated as an alternative
to the fluorescent antinuclear antibody (FANA) as-
*) List of antigens
nDNA = native DNA
UlsnRNP = ... small nuclear ribonucleoprotein
Sm = an antigen, named from the initials of the
patient who showed corresponding antibod-
ies; a nuclear glycoprotein
ANA = antinuclear antibodies
RNP = Ribonucleoprotein
SS-B/La = an antigen B, characterized by sera of certain
patients with Sjögren syndrome (SS)
SS-A/Ro = an antigen A, characterized by sera of certain
patients with Sjögren syndrome (SS)
Scl-70 = an antigen of Mr = 70.000, identified by sera
of certain patients suffering from sclefoderma
(Sc!)
say. Purified nuclei from goat liver were immobilized
on polystyrene plates to detect antinuclear antibodies
(ANA)1) in patients with systemic lupus erythemato-
sus. The effects of the nuclei concentration, storage
of nuclei below 0 °C, and the length of the incubation
period was investigated on the assay. Sera from pa-
tients with systemic lupus erythematosus gave positive
tests. In addition to the sera containing antinuclear
antibodies, prototype sera with antibody specificity1)
to nDNA, UlsnRNP, Sm, nucleosomes, centromere,
ANA (RNP, SS-B/La, SS-A/Ro) and Scl-70 autoan-
tigens were used in this study. Positive results were
obtained with these samples. Sera from normal indi-
viduals were used as controls.
Materials and Methods
Materials
Polystyrene plates from Dynatech, USA, were used as the solid
support for antigen binding. Anti-human IgG alkaline phos-
phatase conjugate, poly D-lysine, poly Z)-glutamate, calf thymus
DNA and bovine serum albumin were from the Sigma Chemical
Company, USA. /?-Nitrophenyl phosphate was obtained from
the C. S. I. R. Centre for Biochemicals, New Delhi. Nonidet P-
40 was from BDH Chemicals, England. A Dynatech ELISA
microplate reader MR 600 was used for absorption measure-
ments.
Eun J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 5
290 ra and Ali: Assay of antinuclear antibodies by BLISA
Sera specimens
Normal human sera and sera from patients with systemic lupus
erythematosus who met the preliminary criteria of the American
Rheumatism Association for this disease (6), were obtained as
described elsewhere (7). All sera were stored at -20°C until
examined and were decomplemented before use by heating at
56 °C for 30 min. Prototype sera were obtained from Centers
for Disease Control, Atlanta, Georgia, USA, and were rehy-
drated by adding 0.5 ml of distilled water.
Preparation of antigen
Goat liver nuclei were isolated as described earlier (8). The
isolated nuclei were suspended in 0.25 mol/1 sucrose, 3 mmol/1
calcium chloride solution (8.0 ml) and carefully layered over
3.0 ml of Ficoll solution (1.0 kg/1 in the sucrose/calcium chloride
solution). The suspension was centrifuged at 700 g for 10 min
and the purified nuclei were collected at the bottom of the
centrifuge tube. The purified nuclei were inspected under the
light microscope using haematoxylin stain.
Enzyme-linked immunosorbent assay
The technique of Aotsuka et al. (9) was used for the detection
and quantitation of anti-DNA antibodies. Direct binding of
antinuclear antibodies to nuclei as antigen (ANA-ELISA) was
determined essentially as previously described (5). A polystyrene
microtitre plate was incubated with 50 μΐ nuclear suspension
(1000 nuclei/50 μΐ in carbonate-bicarbonate buffer, pH 9.6) for
2 h at room temperature and overnight at 4 °C. The plate was
washed three times with saline-Tween 20 and unoccupied sites
were blocked with 10 g/1 bovine serum albumin in saline-Tween
20 for 6 h. Decomplemented sera, dilution in saline-Tween 20,
were adsorbed for 2 h and overnight at 4°C. The unbound
material was washed four times with saline-Tween 20 and anti-
human alkaline phosphatase conjugate (1:1500 dilution in
saline-Tween 20) was added. After 2 h at room temperature,
the plate was washed three times with saline-Tween 20. The
substrate (p-nitrophenyl phosphate, 5 mmol/1 in carbonate buf-
fer containing 2 mmol/1 magnesium chloride, pH 9.5) was added
and absorbance was recorded at 410 nm after appropriate
colour development. In each step 100 μΐ of solution was added
and each sample was run in duplicate. The control wells were
treated similarly but were devoid of antigen. Sera were tested
at a dilution of 1:1000 unless mentioned otherwise.
Data analysis
Values obtained with 25 normal healthy individuals were used
for determining the cut off level for distinguishing antibody-
positive and antibody-negative samples. A value of twice the
standard deviation above the mean, i. e. 0.20, was chosen as a
cut off value. A test sample was positive if the mean absorbance
of duplicate measurements was greater than 0.20 and negative
if the mean absorbance was lower.
Accuracy and precision studies
The reprpducibility of the assay procedure was ascertained by
determining the intra- and inter-assay coefficient of variation
for three normal and seven antinuclear antibody positive sys-
temic lupus erythematosus sera. These samples were tested
seven times in one day in order to determine the intra-assay
coefficient of variation, whereas testing of the same samples
for seven consecutive days gave the inter-assay coefficient of
variation.
Results
Nuclei from goat liver were used as antigen for the
ELISA. The isolated nuclei were 90% pure, based on
staining with haematoxylin, epd the total particle
count. Mitochondria and lysosomal particles ac-
counted for less than 0.1% of the total particles in
the nuclear preparations. Small amorphous compo-
nents were present in amounts ranging from 1 — 8%.
A series of preliminary experiments were carried out
to determine the effect of certain variables on assay
procedure.
Storage of nuclei
When the ELISA was carried out with nuclei that had
been stored up to two weeks at —20 °C, almost no
change in antibody binding was observed. However,
a considerable decrease in binding was observed when
the nuclei had been stored for longer periods (fig. 1).
It is suggested that isolated nuclei stored at —20 °C
can be used for the ELISA for about two weeks
without appreciable loss in antigenicity.
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Fig. 1. Effect of incubation on antibody activity of isolated
nuclei. Isolated nuclei were stored at below 0°C for
different time intervals.
Fixing of nuclei
The nuclei become tightly adsorbed to the polystyrene
surface. Repeated washing of adsorbed nuclei with
saline-Tween 20 had almost no effect on the nuclei
count. Binding of nuclei to the polystyrene surface
was found to be 75-80% of added nuclei (fig. 2).
Concentration of nuclei
The ELISA was performed witihi increasing concen-
trations of nuclei at three different dilutions of two
antinuclear antibody-positive systemic lupus erythe-
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Fig. 2. Kinetics of adsorption of nuclei on polystyrene plate.
The wells of the microtitre plate were coated with dif-
ferent concentrations of nuclei, and the number of nuclei
adsorbed were determined by their count in the super-
natant before ( — Φ — ) and after (—o —), ( — x — ) wash-
ing. The data represent a mean ± S. D. of three deter-
minations.
matosus sera. Antibody binding reached a maximum
at 1000 nuclei bound per well. Further increases in
the concentration of bound nuclei were accompanied
by a marked decrease in antibody binding (fig. 3).
The antibody binding profile was similar with differ-
ent dilutions of each serum. In view of the sudden
drop in antibody binding following any attempt to
increase the coating above 1000 nuclei/well, the ex-
periment was repeated three times to ascertain data
reproducibility. Each time an almost identical profile
was obtained.
0.2 1.0 10
Number of nuclei coated [103]
Fig. 3. Evaluation of the critical concentration of nuclei for the
antinuclear antibody ELISA. Three different dilutions
of two systemic lupus erythematosus sera (—·—),
(-0-), (-X-) and (-·-), <- A-), (-D-).
ANA-ELISA
Normal human sera, and sera of systemic hipus ery-
thematosus patients with different level of antibody
activity, were tested for antinuclear antibodies with
the ELISA at various dilutions of serum. Ten out of
twelve (83%) systemic lupus erythematosus patients
were positive for antibodies to antinuclear antibodies
when purified nuclei were used as antigen. In figure
4, titrations of three sera from systemic lupus erythe-
matosus patients are compared with a normal human
serum. The ELISA was also carried out with samples
of systemic lupus erythematosus sera, using nDNA
as antigen. Figure 5 shows the results obtained with
various antibody-positive systemic lupus erythema-
tosus sera.
3.3 3.6 3.9
-log serum dilution
Fig. 4. Direct binding assay of antinuclear antibodies. (—o—),
(—o—), ( — x — ) antinuclear antibody-positive systemic
lupus erythematosus serum with different levels of an-
tibody activity. ( — β — ) normal human serum.
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Fig. 5. Antibody binding profile of twelve systemic lupus ery-
thematosus sera. Native DNA (m) and purified nuclei
(·). Normal human serum with either of the antigens
(D).
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The reference sera from the Centers for Disease Con-
trol, Atlanta, Georgia, USA, with antibody specificity
for nDNA, RNP, Sm, nucleolus, centromere, ANA
(RNP, SS-B/La, SS-A/Ro) and Scl-70 were analysed
for their antibody content against nuclei, using the
EL1SA. All the prototype sera demonstrated strong
antibody binding. The characteristic of reference sera
as provided by the supplier and the titre obtained by
ANA-ELISA are shown in table 1. The end point
titre for individual sera is expressed as the mean of
duplicate samples. Normal human sera and sera from
patients with non-autoimmune diseases (25 serum
samples) were negative for antinuclear antibodies.
Tab. 1. Comparison of the antinuclear antibody (ANA) reac-
tivity of the FANA and the ANA-ELISA, using pro-
totype sera
ΑΝΑ-human
reference
serum No.
1.
2.
3.
4.
5.
6.
7.
Antibody
activity
•
 v
 against
nDNA
ANA**
UlsnRNP
Sm
Nucleolar
Centromere
Scl-70
FANA
median
titre*
1 :
1 :
ID1:
ID1 :
1 :
1 :
ID1 :
512
320
64
64
256
640
4
ANA-
ELISA
titre
1 : 3200
1 : 1600
> 1 : 3200
>1:3200
1 : 3200
1 : 1600
1 : 3200
* Provided by the Centers for Disease Control, Georgia, USA.
** UlRNP/SSB-La/SSA-Ro
ID = immunodiffusion
Tab. 2. Reproducibility data for antinuclear antibody assay of
systemic lupus erythematosus and normal human sera
Serum
No.
Systemic lupus
1.
2.
3.
4.
5.
6.
7.
··
Normal human
8.
9.
10.
Mean absorbance +
Intra-assay
erylhematosus
0.825 + 0.01 1
(1.33)
0.754 + 0.009
(1.19)
0.630 + 0.012
(1.90)
0.654 + 0.010
(1.52)
0.454 + 0.008
(1.76)
0.385 ± 0.008
(2.15)
. 0.390 + 0.009
(2.30)
sera
0.180 -f 0.004
(2.22)
0.220 ± 0.002
(0.909)
0.195 ± 0.005
(2.56)
S.D.
Inter-assay
0.840 + 0.030
(3.57)
0.715 + 0.025
(3.49)
0.695 + 0.035
(5.03)
0.621 + 0.032
(5.15) .
0.520 + 0.030
(5.76)
. 0.430 + 0.050
(11.62)
0.380 + 0.031
(8.15)
0.180 ±!o.020
(11.1) "
0:250 + 0.020
(8.00)
0.200 + 0.020
(10.0)
The values in parentheses represent coefficient of variation.
Serum dilution was 1 :1000.
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Precision
Table 2 shows the intra- and inter-assay coefficients
of variation for the measurement of antinuclear an-
tibodies in seven positive systepiic lupus erythema-
tosus sera. A high degree of reproducibility of the
assay procedure is evident from the data.
Discussion
The fluorescent antinuclear antibody (FANA) tech-
nique of Coons & Kaplan (10) has become important
as a widely used method for detecting antinuclear
antibodies in the sera of patients with autoimmune
diseases. Despite being the established method for
detecting and quantifying antibodies, FANA has cer-
tain limitations, e. g. the use of fluorescent micros-
copy, wide variation in reagent quality, and the lack
of a standard substrate for detecting a variety of
autoantibodies (11, 12).
The studies reported here indicate that the identifi-
cation of antibodies to nuclear antigens can be con-
veniently carried out with the ELISA, employing pu-
rified nuclei as the source of antigen.
In preliminary studies we observed a nearly linear
relationship between antibody binding and nuclei con-
centration up to 1000 nuclei/well; further increases in
the concentration of bound nuclei were accompanied
by a marked decrease in antibody binding. Re-testing
of sera at different dilutions yielded similar binding
profile. It is possible that at higher concentrations the
nuclei were adsorbed in layers which were easily lost
during washing.
Sera of 12 systemic lupus erythematosus patients were
examined with the ELISA, using nDNA and purified
nuclei as the antigens. With two exceptions, a high
titre of antibody binding against each of these two
antigens was observed. One patient displayed high
titre antibodies to nuclei, but showed a negative re-
action with nDNA. This difference in antigen recog-
nition could be due to the presence of antibodies in
systemic lupus erythematosus sera against a nuclear
antigen different from DNA. In contrast, another
patient, although positive for anti-DNA antibody ac-
tivity, showed a reaction with nuclei. The heteroge-
neity of systemic lupus erythematosus sera is well
documented, and the antibody binding could be due
to recognition of single stranded regions in nDNA
which are practically impossible to remove totally.
With this technique, antibodies were readily detected,
with maximal reactivity at a» serum dilution of
1 :1000; this is a significantly higher titre than the
1 :100 observed for nDNA binding.
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Examination of various reference sera with known
antibody specificities clearly demonstrated the sensi-
tivity of the technique. The most prominent of our
finding was a high reactivity towards RNP, Sm,
nDNA, nucleolar and Scl-70 sera, with end point litres
higher than in the FANA assay (tab. 1).
In summary, the method described for detection of
antinuclear antibodies is a reliable alternative to
FANA. It is more convenient to perform, and it
produces quantitative, reproducible data, with a high
degree of accuracy that is acceptable for most sero-
logical assays involving serial dilution of serum.
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